MedTrace Logo

Maternal Hypertriglyceridaemia Study

NCT02479113 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2016-11-01

No results posted yet for this study

Summary

Besides maternal hyperglycemia, a strong link between maternal pregravid weight/maternal triglyceride(Tg) levels and fetal growth/childhood obesity/metabolic syndrome in offspring has been demonstrated in largely Caucasian populations. This study aims to explore the link between maternal hypertriglyceridemia and offspring health in Asians.

Conditions

  • Metabolic Syndrome X

Interventions

PROCEDURE

Blood sampling

At 12 - 32 weeks: All patients need blood sampling for OGTT + insulin + C-peptide + fasting triglyceride + NEFA At 36 weeks/ delivery: All patients need blood sampling for fasting glucose + insulin + C-peptide + fasting triglyceride + NEFA At 36 weeks/ delivery: only GDM patients need blood sampling for HbA1c + fructosamine

Sponsors & Collaborators

  • University of Malaya

    lead OTHER

Principal Investigators

  • Shireene Vethakkan, MD · University of Malaya

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2018-12-31
Completion
2024-12-31

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02479113 on ClinicalTrials.gov